Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Immunology

Welcome to Your HAE Journey: Relief, Reality, and Results

At a Glance

Hereditary Angioedema (HAE) is a genetic condition causing unpredictable swelling driven by bradykinin, not histamine. Because it is not an allergy, typical allergy medications do not work. However, modern preventative treatments can successfully reduce attacks by 90 percent or more.

If you have spent years—or even decades—wondering why your body suddenly swells without warning, receiving a diagnosis of Hereditary Angioedema (HAE) often brings a complicated mix of relief and anxiety [1]. You are not alone in this long search; many patients face a diagnostic delay of 10 to 20 years, during which they are frequently misdiagnosed with severe allergies or even mistaken for having appendicitis [1][2].

Understanding HAE is the first step toward taking control of your health. While it is a chronic, lifelong condition, the landscape of treatment has changed dramatically in recent years, allowing most patients to lead full, active lives [3][4].

Why HAE is Not an Allergy

The most critical thing to understand about HAE is that it is not an allergy. In a typical allergic reaction, your body releases histamine, which causes itching and hives [5][6]. In HAE, the swelling is caused by an excess of a different substance called bradykinin [7].

Bradykinin is a peptide that helps regulate blood pressure by dilating blood vessels [7]. In HAE, a genetic mutation causes a deficiency or dysfunction in a protein called C1-esterase inhibitor [7][8]. Without enough working C1-inhibitor, your body produces too much bradykinin, which makes your blood vessels “leaky,” allowing fluid to pour into the surrounding tissues and cause swelling [7][9].

This mutation is passed down in an autosomal dominant pattern [10]. This means if you have HAE, there is a 50% chance of passing the condition to each of your children, making family screening very important [11].

Because HAE is not driven by histamine:

  • Antihistamines (like Benadryl) will not work [5][12].
  • Corticosteroids (like Prednisone) will not work [5][12].
  • Epinephrine (EpiPens) is generally ineffective for HAE-specific swelling [5][13].

Three Stabilizing Facts for Your Journey

  1. Modern Treatments are Highly Effective: We have entered a new era of “long-term prophylaxis” (preventative treatment). Modern medications, such as monoclonal antibodies that inhibit the protein kallikrein, can reduce the frequency of attacks by 90% or more for many patients [4][14].
  2. You Can Be Your Own First Responder: Education on self-administration of medication is a cornerstone of HAE care. While the thought of administering treatments into a vein (IV) or under the skin may sound terrifying, specialized nurses will provide comprehensive, hands-on training so you are never left to figure it out alone. Patients who self-administer report a much higher quality of life and less anxiety [15][16].
  3. Your Future is Not Defined by Swelling: The goal of modern HAE management is “total control.” This means working with your doctor to reach a point where you have zero attacks and no interference with your daily life [17][18].

Understanding Your Symptoms

HAE attacks are unpredictable, but they often follow a pattern. Swelling typically develops over several hours and can last for 2 to 5 days if left untreated [19].

Feature Histamine (Allergy) Bradykinin (HAE)
Itching Common and intense Rare or absent [5]
Hives Common (raised, red welts) Absent (though a non-itchy rash may occur) [5]
Speed Very rapid (minutes) Slower onset (hours) [19]
Response to Epinephrine Effective Ineffective [5]

Many patients experience a “warning sign” known as a prodrome before the swelling starts [19]. This might include extreme fatigue, tingling at the site, or a unique, map-like skin redness called erythema marginatum that does not itch [19]. Recognizing these signs early allows you to use your rescue medication sooner, which is the most effective way to stop an attack in its tracks [17].

Return to Home Page

Common questions in this guide

Why don't allergy medicines like Benadryl or EpiPens work for HAE?
HAE swelling is caused by an excess of a peptide called bradykinin, rather than histamine. Because HAE is not an allergic reaction, standard allergy treatments like antihistamines, corticosteroids, and epinephrine are generally ineffective.
How is HAE swelling different from a normal allergic reaction?
Unlike typical allergic reactions, HAE swelling develops slowly over hours and typically does not cause itching or hives. Before the swelling starts, you might also experience warning signs like profound fatigue, tingling, or a non-itchy rash.
Can I pass Hereditary Angioedema down to my children?
Yes, HAE is passed down in an autosomal dominant pattern. This means that if you have HAE, there is a 50 percent chance of passing the condition to each of your children, making genetic screening for family members very important.
Is it possible to prevent HAE swelling attacks?
Yes. Modern preventative treatments, known as long-term prophylaxis, can reduce attack frequency by 90 percent or more. The ultimate goal of modern HAE care is achieving 'total control' where you experience zero attacks.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my history of symptoms, how long was my diagnostic delay compared to the average?
  2. 2.Can you confirm that my swelling is bradykinin-mediated and not histamine-mediated?
  3. 3.What specific HAE-specific rescue medications should I have on hand at all times?
  4. 4.Since HAE is autosomal dominant, what is the process for testing my first-degree relatives?
  5. 5.Which prophylactic (preventative) treatment options are best suited for my lifestyle?
  6. 6.How can I distinguish between a 'prodromal' non-itchy rash and an allergic reaction?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (19)
  1. 1

    Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting.

    Zanichelli A, Longhurst HJ, Maurer M, et al.

    Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology 2016; (117(4)):394-398 doi:10.1016/j.anai.2016.08.014.

    PMID: 27742086
  2. 2

    A Two-Decade-Delayed Diagnosis of Hereditary Angioedema: A Case Report.

    Shrestha S, Yadav AK, Khadka D, et al.

    Cureus 2025; (17(5)):e85019 doi:10.7759/cureus.85019.

    PMID: 40585652
  3. 3

    Garadacimab for hereditary angioedema attack prevention: long-term efficacy, quality of life, and safety data from a phase 2, randomised, open-label extension study.

    Craig TJ, Levy DS, Reshef A, et al.

    The Lancet. Haematology 2024; (11(6)):e436-e447 doi:10.1016/S2352-3026(24)00081-4.

    PMID: 38710185
  4. 4

    Initial Experience of Long-Term Prophylaxis with Lanadelumab for Hereditary Angioedema in China: A Clinical Observation Study on Six Patients.

    Yao W, Diao R, Yang B, et al.

    International archives of allergy and immunology 2025; (186(3)):221-231 doi:10.1159/000541242.

    PMID: 39362190
  5. 5

    Differences and Similarities in the Mechanisms and Clinical Expression of Bradykinin-Mediated vs. Mast Cell-Mediated Angioedema.

    Maurer M, Magerl M

    Clinical reviews in allergy & immunology 2021; (61(1)):40-49 doi:10.1007/s12016-021-08841-w.

    PMID: 33534062
  6. 6

    When the Red Tide Rolls In: A Red Tide Associated Angioedema Case Report.

    Rabinowitz S, Solano JJ

    Clinical practice and cases in emergency medicine 2021; (5(2)):222-225 doi:10.5811/cpcem.2021.3.51920.

    PMID: 34437010
  7. 7

    Hereditary angioedema: Pathophysiology (HAE type I, HAE type II, and HAE nC1-INH).

    Wedner HJ

    Allergy and asthma proceedings 2020; (41(Suppl 1)):S14-S17 doi:10.2500/aap.2020.41.200081.

    PMID: 33109319
  8. 8

    HAE Pathophysiology and Underlying Mechanisms.

    Zuraw BL, Christiansen SC

    Clinical reviews in allergy & immunology 2016; (51(2)):216-29 doi:10.1007/s12016-016-8561-8.

    PMID: 27459852
  9. 9

    Hereditary angioedema: current therapeutic management and future approaches.

    Lamacchia D, Nappi E, Marzio V, et al.

    Current opinion in allergy and clinical immunology 2024; (24(4)):257-265 doi:10.1097/ACI.0000000000000992.

    PMID: 38743499
  10. 10

    Delayed diagnosis of hereditary angioedema with C1-inhibitor deficiency in iranian children and adolescents.

    Ayazi M, Fazlollahi MR, Mohammadzadeh I, et al.

    Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology 2019; (30(3)):395-398 doi:10.1111/pai.13028.

    PMID: 30690789
  11. 11

    Identification of an elusive SERPING1 deletion in a family with hereditary angioedema type I utilizing soft clipping.

    Wetherby K, Chiao J, Faulkner E, et al.

    Frontiers in allergy 2025; (6()):1565283 doi:10.3389/falgy.2025.1565283.

    PMID: 40313637
  12. 12

    Management of hereditary angioedema in resource-constrained settings: A consensus statement from Indian subcontinent.

    Jindal AK, Sil A, Aggarwal R, et al.

    Asia Pacific allergy 2023; (13(2)):60-65 doi:10.5415/apallergy.0000000000000100.

    PMID: 37388810
  13. 13

    Real-world off-label use of icatibant for acute management of non-hereditary angioedema.

    Le TA, Smith W, Hissaria P

    Internal medicine journal 2021; (51(3)):419-423 doi:10.1111/imj.15241.

    PMID: 33738947
  14. 14

    Effect of lanadelumab on attack frequency and QoL in Japanese patients with hereditary angioedema: Report of five cases.

    Hioki C, Oda Y, Moriwaki S, Fukunaga A

    The Journal of dermatology 2024; (51(6)):873-877 doi:10.1111/1346-8138.17106.

    PMID: 38268496
  15. 15

    Hereditary angioedema: an update on causes, manifestations and treatment.

    Longhurst HJ, Bork K

    British journal of hospital medicine (London, England : 2005) 2019; (80(7)):391-398 doi:10.12968/hmed.2019.80.7.391.

    PMID: 31283393
  16. 16

    Impact of providing education on the recognition and differential diagnosis of angioedema among emergency department physicians.

    Unal D, Demir S, Işik SR, et al.

    The World Allergy Organization journal 2025; (18(8)):101101 doi:10.1016/j.waojou.2025.101101.

    PMID: 40822745
  17. 17

    Treatment Patterns and Characteristics of Patients with Hereditary Angioedema Treated with Lanadelumab: A US Retrospective Chart Review.

    Watt M, Chang R, Yu LH, et al.

    Drugs - real world outcomes 2025; (12(3)):351-365 doi:10.1007/s40801-025-00505-x.

    PMID: 40665203
  18. 18

    Patient Preferences for Long-Term Prophylactic Treatment in Hereditary Angioedema: A Discrete-Choice Experiment.

    Villa KF, Mansfield C, Yarlas A, et al.

    The patient 2026; (19(3)):481-495 doi:10.1007/s40271-025-00798-8.

    PMID: 41565919
  19. 19

    Emerging drugs for the treatment of hereditary angioedema due to C1-inhibitor deficiency.

    Zanichelli A, Montinaro V, Triggiani M, et al.

    Expert opinion on emerging drugs 2022; (27(2)):103-110 doi:10.1080/14728214.2022.2105834.

    PMID: 35876094

This page provides educational information about Hereditary Angioedema (HAE). It is not a substitute for professional medical advice, diagnosis, or treatment from your immunologist or healthcare provider.

Get notified when new evidence is published on Hereditary angioedema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.